Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Triantafillidou, P. Lyberopoulos, L. Kolilekas, K. Kagouridis, S. Gyftopoulos, C. Sotiropoulou, A. Kotanidou, A. Karakatsani, S. Papiris (Athens, Greece). The prognostic significance of cardiopulmonary exercise in IPF. Eur Respir J 2011; 38: Suppl. 55, 659

Member's Comments

No comment yet.

Related content which might interest you: The prognostic role of cardiopulmonary exercise testing in disease Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing Year: 2019 The prognostic role of cardiopulmonary exercise testing in disease Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing Year: 2018 The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing Year: 2011 Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020 Year: 2020 Prognostic predictors for survival in patients with COPD using cardiopulmonary testing Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 The prognostic value of exercise testing Source: Breathe 2009; 5: 229-234 Year: 2009 Cardiopulmonary exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 88s Year: 2003 Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020 Year: 2021 The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Any role for cardiopulmonary exercise test in symptomatic smokers with borderline spirometry? Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases Year: 2018 Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing Source: Eur Respir Rev 2016; 25: 333-347 Year: 2016 Chronotropic incompetence during maximal cardiopulmonary exercise test in patients with COPD and CHF Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009 The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021 Year: 2021 Cardiopulmonary exercise testing as non-invasive tool for CTEPH treatment effect assessment Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions Year: 2021